Quantitative Proteomics Identifies Reduced NRF2 Activity and Mitochondrial Dysfunction in Atopic Dermatitis-Reference-Cited by-同舟云学术

Quantitative Proteomics Identifies Reduced NRF2 Activity and Mitochondrial Dysfunction in Atopic Dermatitis

Published:2023-02 Issue:2 Volume:143 Page:220-231.e7
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Koch Michael^ORCID,Kockmann Tobias^ORCID,Rodriguez Elke^ORCID,Wehkamp Ulrike^ORCID,Hiebert Paul^ORCID,Ben-Yehuda Greenwald Maya^ORCID,Stölzl Dora^ORCID,Beer Hans-Dietmar^ORCID,Tschachler Erwin^ORCID,Weidinger Stephan^ORCID,Werner Sabine^ORCID,auf dem Keller Ulrich^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference64 articles.

1. Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice;Athale;Free Radic Biol Med,2012

2. Large-scale quantitative proteomics identifies the ubiquitin ligase Nedd4-1 as an essential regulator of liver regeneration;Bachofner;Dev Cell,2017

3. The molecular mechanisms regulating the KEAP1-NRF2 pathway;Baird;Mol Cell Biol,2020

4. Oxidative stress and atopic dermatitis;Bertino;Antioxidants (Basel),2020

5. Phosphorylation of Nrf2 at Ser40 by Protein Kinase C in Response to Antioxidants Leads to the Release of Nrf2 from INrf2, but Is Not Required for Nrf2 Stabilization/Accumulation in the Nucleus and Transcriptional Activation of Antioxidant Response Element-mediated NAD(P)H:Quinone Oxidoreductase-1 Gene Expression

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence;Journal of Investigative Dermatology;2024-06

2. Screening mitochondria-related biomarkers in skin and plasma of atopic dermatitis patients by bioinformatics analysis and machine learning;Frontiers in Immunology;2024-05-07

3. Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials;Journal of the American Academy of Dermatology;2024-05

4. TRPV3-Activated PARP1/AIFM1/MIF Axis through Oxidative Stress Contributes to Atopic Dermatitis;Journal of Investigative Dermatology;2024-05

5. Dermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature;International Journal of Molecular Sciences;2024-03-14